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Abstract
Intestinal microfold (M) cells possess a high transcytosis capacity and are able to transport a broad range of materials
including particulate antigens, soluble macromolecules, and pathogens from the intestinal lumen to inductive sites of the
mucosal immune system. M cells are also the primary pathway for delivery of secretory IgA (SIgA) to the gut-associated
lymphoid tissue. However, although the consequences of SIgA uptake by M cells are now well known and described, the
mechanisms whereby SIgA is selectively bound and taken up remain poorly understood. Here we first demonstrate that
both the Ca1 region and glycosylation, more particularly sialic acid residues, are involved in M cell–mediated reverse
transcytosis. Second, we found that SIgA is taken up by M cells via the Dectin-1 receptor, with the possible involvement of
Siglec-5 acting as a co-receptor. Third, we establish that transcytosed SIgA is taken up by mucosal CX3CR1+ dendritic cells
(DCs) via the DC-SIGN receptor. Fourth, we show that mucosal and systemic antibody responses against the HIV p24-SIgA
complexes administered orally is strictly dependent on the expression of Dectin-1. Having deciphered the mechanisms
leading to specific targeting of SIgA-based Ag complexes paves the way to the use of such a vehicle for mucosal vaccination
against various infectious diseases.
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Introduction
The mucosal immune system comprises the largest part of the
entire immune system, and the mucosal surface represents the
primary site of entry for pathogenic agents. SIgA has long been
recognized as a first line of defense in protecting the intestinal
epithelium from enteric pathogens and toxins. It is generally
assumed that SIgA acts primarily through receptor blockade, steric
hindrance, and/or immune exclusion. In recent years evidence has
emerged indicating that SIgA promotes the uptake and delivery of
Ags from the intestinal lumen to DC subsets located in gut-
associated lymphoid tissues (GALTs), and influences inflammatory
responses normally associated with the uptake of highly pathogenic
bacteria and potentially allergenic antigens. This particular feature
of SIgA, called reverse transcytosis, is mediated by epithelial M cells
[1]. However, although the potentially useful properties of M cells
on SIgA uptake are now well known, the receptor(s) whereby SIgA
is taken up and transported by M cells remain(s) elusive.
SIgA reverse transcytosis was first invoked to account for the
binding of rabbit SIgA to M cells in Peyer’s patches (PPs) of
suckling rabbits [2]. Colloidal gold particles coated with IgA were
subsequently detected within M cell cytoplasmic vesicles and in the
extracellular space of M cell pockets [3]. Endogenous SIgA was
also shown to bind to human PP M cells in paraffin sections of
human ileum [4]. In frozen sections, labeled SIgA could be
visualized bound at the apical surface, in transit through
intracellular vesicles, in the intraepithelial pocket, and on
basolateral processes extending toward the basal lamina. In a
mouse ligated ileal loop assay, mouse SIgA, human SIgA2, but not
human SIgA1, bound to PP M cells [4]. Structural changes could
explain the differences in reverse transcytosis between these
subtypes. The IgA1 hinge features a 16 amino-acid insertion,
lacking in IgA2, comprising a repeat of eight amino acids
decorated with 3–5 O-linked oligosaccharides [5,6]. Recombinant
IgA1 with a deleted hinge region gained M cell binding function,
which was interpreted as the M cell’s binding site comprising both
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domains Ca1 and Ca2, juxtaposed in mouse IgA and human IgA2
[4]. Overall, IgA2 contains 4 N-glycosylation sites (Asn166, Asn263,
Asn337, Asn459). In dimeric IgA, the Fc regions of the two
monomers are linked end to end through disulfide bridges to the J
chain [7]. IgA, with or without bound secretory component (SC),
selectively adheres to the apical surfaces of mouse PP M cells [4].
To date, only a limited number of M cell receptors and their
ligands have been identified, but most of these receptors are
expressed in M cells and neighboring enterocytes as well. Some
important pathogen recognition receptors, such as toll-like
receptor-4, platelet-activating factor receptor, and a5b1 integrin
have been identified on the surface of human and mouse M cells
[8,9]. The sialyl Lewis A (CA19.9) antigen lectin reacts with 80%
of human M cells and, in contrast to the other ligands, binds only
weakly to the enterocytes of the follicle-associated epithelium
(FAE). Moreover, there is a wide variation in marker expression
between M cells of different species and even between M cells at
different portions of the intestine within the same species [10].
Indeed, M cells in murine, but not human, PP are preferentially
bound with Ulex europaeus agglutinin–1 (UEA-1), a lectin specific
to a-l-fucose residues [11]. A first mouse M cell–specific
monoclonal antibody (mAb NKM 16-2-4) [12] displaying
specificity for a(1,2)-fucose–containing carbohydrate moieties
was produced. Glycoprotein 2 (GP2) was also shown to be
specifically expressed on M cells of mouse and human PPs [13–15]
and serves as an endocytic receptor for luminal antigens [16].
Another M cell marker, clusterin, is expressed in M cells and
follicular DCs at inductive sites of human GALTs [14].
To date, the molecular partner(s) involved in SIgA reverse
transcytosis has(have) not been identified in mice or in humans. In
this work, we sought to map the structural feature(s) responsible for
the selective interaction between murine SIgA and M cells.
Since it is impossible to keep M cells in culture, one valuable
approach consists in using cell culture models that mimic
essential features of the FAE tissue. An in vitro model was used,
based on the co-culture of polarized Caco-2 cells grown on
inverted inserts and exposed to human Raji B lymphocytes
[17,18]. Following optimization in terms of functionality and
reproducibility, we evaluated the transport of wild-type (wt) and
mutant human IgA2 across newly differentiated M-like cells in
comparison with other Ab isotypes. We found that glycosylation
sites and in particular sialylation of the Ca1 region of IgA2 are
required for M-like cell-mediated reverse transcytosis. We
demonstrate for the first time that Dectin-1 expressed on the
surface of M cells acts as a receptor involved in SIgA reverse
transcytosis both in vitro and in vivo. Siglec-5 receptor seems also
to participate in reverse transcytosis. Such a selective interaction
has functional consequences in vivo, since targeting of HIV p24-
SIgA complexes after oral delivery promotes the production of
systemic and mucosal Ag-specific Abs in wt mice only, and not
in Dectin-1 KO animals.
Results
Establishment of an in Vitro Model of Human FAE
The model was adapted as described in the Methods section to
optimize its reproducibility (Figure 1a). Prior to adding the
lymphocytes, the tightness of the Caco-2 cell monolayer was
checked by measuring transepithelial electrical resistance (TEER).
The decrease in TEER observed after 5 d of co-culture is
indicative of Caco-2 cell conversion into M cells (Figure 1b) [19]
but not a result of the deterioration of tight junction organization,
as reflected by preserved ZO-1 immunolabeling (Figure 1c), of
either mono- or co-cultures.
M cells display a reduced brush border at their apical surface
and an invaginated basolateral membrane, forming a pocket
filled with immunoreactive cells [3]. Transmission electron
microscopy shows that mono-cultures of Caco-2 cells exhibit a
well-developed brush border with tightly packed microvilli,
whereas in co-cultures with Raji cells, M-like cells characterized
by the effacement of microvilli and enfolded lymphocytes are
present (Figure 1d1). Moreover, the presence of desmosomes
between M-like cells and the neighboring cells reveals their
enterocytic origin (Figure 1d1, inset). Using scanning electron
microscopy analysis, we observed in mono-cultures that all
Caco-2 cells possessed a regular brush border and well-
developed tight junctions, whereas in co-cultures, approximately
20–30% of Caco-2 cells expressed short and irregular microvilli
(Figure 1d2) [20]. Immunolabeling of M-like cells with CA19.9
and enterocytes with UEA-1 (Ulex europaeus isoagglutinin I)
[21] indicated a similar percentage of conversion, assuming a
surface equivalence for M and Caco-2 cells (Figure 1e1). This
was further verified by co-localization of human IgA2 with M
cells labeled with CA19.9 mAb (Figure 1e2), in agreement with
Mantis et al. [4].
To verify functional Caco-2 cell conversion into M cells, the
transport of yellow/green-conjugated, 0.2 mm nanoparticles (NPs)
across mono- and co-cultures was examined. NPs have previously
been used to study transcytosis in various M-like cell models in vitro
and in vivo [22]. The number of transported NPs recovered in the
basal medium was 5.5-fold higher in the co-cultures, compared to
Caco-2 cell mono-cultures (p,0.001) (Figure 1f). The sum of these
data confirmed that the in vitro model of human FAE allowed
efficient Caco-2 cells to M-like cell conversion to occur (20–30%),
and importantly, with a high level of reproducibility.
Author Summary
Secretory IgA (SIgA) antibodies are secreted into the gut
lumen and are considered to be a first line of defense in
protecting the intestinal epithelium from gut pathogens.
SIgA patrol the mucus and are usually known to help
immune tolerance via entrapping dietary antigens and
microorganisms and other mechanisms. SIgA, in complex
with its antigens, can also be taken back up by the
intestinal epithelium in a process known as reverse
transcytosis. SIgA can thereby promote the uptake and
delivery of antigens from the intestinal lumen to the Gut-
Associated Lymphoid Tissues (GALT), influencing inflam-
matory responses. This reverse transcytosis of SIgA is
mediated by specialized epithelial M cells. Because M cells
possess the ability to take up antigens and are therefore
important to the local immune system, they are a key
target for the specific delivery of novel mucosal vaccines
against various diseases. M cell receptors that take up the
SIgA-antigen complexes, which serve as mucosal vaccine
vehicles, represent an important aspect of this vaccine
strategy. The identification of SIgA receptor(s) on the
surface of M cells has, however, remained elusive for more
than a decade. In this study, we now identify Dectin-1 and
Siglec-5 as the key receptors for M cell–mediated reverse
transcytosis of SIgA complexes. We further find that the
glycosylation modification, and particularly sialylation, of
SIgA is required for its uptake by M cells. We show that,
when administered orally in complex with SIgA, the HIV
p24 antigen is taken up in a strictly Dectin-1-dependent
manner to stimulate a mucosal and systemic antibody
response. These findings are considered important for
understanding gut immunity.
Glycan-Dependent SIgA Reverse Transcytosis
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Characterization of the Antibody Constructs
Wt and truncated/mutated Ab constructs depicted in Figure 2
were cloned in the pGTRIO expression vector, stably
transfected in CHO cells, produced in the culture supernatant,
and purified by affinity chromatography as described in the
Methods section. SDS-PAGE performed under reducing and
nonreducing conditions confirmed the expected molecular
weight for the light and heavy chains of the various constructs
Figure 1. Validation and characterization of the inverted in vitro model of human FAE. (a) Schematic representation of the successive
steps leading to the establishment of the M-like cell-containing Caco-2 cell monolayer. Molecular and cellular partners added as a function of the
experimental setting are depicted. D, day. (b) Slight decrease of transepithelial electrical resistance (TEER) was observed during M cell conversion of
polarized Caco-2 cell monolayer. (c) Localization by immunofluorescence of ZO-1 and CA19.9 in the mono- and co-culture models shows tight
intercellular junctions around CA19.9+ M cells (top view). (d1) Identification of M-like cells by transmission electron microscopy (TEM). In co-culture,
M-like cells were identified by the effacement of microvilli at the apical surface and the presence of enfolded lymphocytes (side view). Mono-cultures
present a columnar shape as well as a brush border. (d2) Scanning electron microscopy (SEM) confirmed the presence of M-like cells and the lack of
microvilli at their apical surface (top view). (e1) Identification and localization of M-like cells and enterocyte cells by immunofluorescence staining with
anti-CA19.9-PE mAb and lectin UEA-1-FITC, respectively (top view). (e2) Co-localization evaluated by immunofluorescence microscopy of CA19.9-PE
and IgA2-GFP indicates binding of the Ab to M-like cells (top view). (f) Increased apical-to-basolateral transport of 0.2 mm yellow-green-conjugated
NPs across the co-cultures as compared to mono-cultures. Absence of transport at 4uC is indicative of an active membrane trafficking process. Each
set of experiments was repeated at least twice.
doi:10.1371/journal.pbio.1001658.g001
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produced, and indicated assembly despite reduced formation of
disulfide bridges between heavy and light chains (Figure 2), a
feature commonly encountered while expressing IgA Abs in
CHO cells [23].
Structural Features Involved in the Specific Uptake and
Transport of IgA2 in the in vitro Model of Human FAE
One feature of M cells is their ability to transport a broad range
of materials including Abs from the lumen to the underlying
Figure 2. Antibody production. (a) Schematic representation of recombinant IgA2 constructs bearing GFP or Luciferase (Luc) at the N terminus.
Numbers in brackets correspond to the lanes of gels depicted in (b) and (c). Glycosylation sites on asparagine residues (N) are indicated in rectangles
connected to alpha chain domains. (b) Recombinant Igs separated by SDS-PAGE under reducing conditions and stained with Coomassie blue. (c)
Analysis of a selection of recombinant Igs by SDS-PAGE under nonreducing conditions and stained with Coomassie blue. The identification of the
various assembled forms was determined based on immunodetection with Abs specific to the alpha and kappa chains, respectively (not shown). 1,
human m-IgA2 (monomer); 2, human d-IgA2 (dimer carrying the J chain); 3, murine m-IgA (monomer); 4, human IgE; 5, human IgG; 6, human m-IgA1
(monomer); 7, human mI-gA2 (monomer); 8, human m-IgA2 G0 (no glycosylation – monomer); 9, human m-IgA2 G1 (1 glycosylation site (Asn263) –
monomer); 10, human m-IgA2 G2 (2 glycosylations sites (Asn263 and Asn469) – monomer); 11, human m-IgA2 (monomer); 12, human m-IgA2 dPB
(monomer lacking the basal part); 13, human m-IgA2 dCa3 (monomer lacking the basal part and Ca3); 14, human m-IgA2 dCa2/3 (monomer lacking
the basal part, and domains Ca3 and Ca2); 15, human m-IgA2 Ca1 G0 (Ca1 domain only, no glycosylation); 16, human m-IgA2 Ca1 (Ca1domain only).
doi:10.1371/journal.pbio.1001658.g002
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follicles. Specific retro-transport of Abs was compared between
mono- and co-cultures using a luciferase (Luc)-IgA fusion protein.
The Luc tag did not affect the Ab functionality (unpublished data)
and allowed for sensitive quantification. As shown in Figure 3a, a
significant exclusive transport of the IgA2 monomer (m-IgA2)
across the cell monolayer harboring M-like cells was observed
(p=0.03). No significant transport of m-IgA1, IgG, or IgE was
detected. Specificity of IgA reverse transcytosis was further
confirmed in vivo by using a ligated murine intestinal loop. IgA
positive cells were 30 times more abundant than IgG positive cells
in PPs (Figure 3b). Dimerization, by incorporation of the J chain,
or association with human SC did not modify IgA2 uptake by M-
like cells (Figure 3a).
Next, mapping of regions and domains involved in IgA2 reverse
transcytosis was performed with recombinant IgA2 lacking various
portions of the heavy chain C-terminus (Figure 3a). IgA2
Figure 3. Specific transport of IgA2-Luc across the in vitro model of human FAE and in a mouse ligated loop containing a PP. (a)
Mono- and co-cultures were incubated for 90 min at 37uC with various IgA2 constructs, and transported IgA was evaluated by associated
luminescence (n= 4). The transport of m-IgA2, d-IgA2, d-IgA2+SC, m-IgA2 Ca1, and m-IgA2 dCa2/3 was significantly promoted in the co-cultures
compared with the mono-cultures. (b) Only murine SIgA-Cy3, but not IgG2a-PE, incubated for 60 min in a mouse ligated intestinal loop is efficiently
transported in underlying lymphoid tissues. Dotted lines delineate the interface between the intestinal lumen and tissue (FAE, side view). SIgA or
IgG2a positive cells were quantified from three individual PPs.
doi:10.1371/journal.pbio.1001658.g003
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monomer depleted of Ca2, Ca3, and the tailpiece (m-IgA2 dCa2/
3) crossed M-like cells as well as m-IgA2 wt, whereas IgA2
monomer depleted of the tailpiece (m-IgA2 dPB) and IgA2
monomer depleted of both the Ca3 and tailpiece (m-IgA2 dCa3)
were not transported. The hinge region did not influence uptake as
m-IgA2 dCa2/3 and m-IgA2 Ca1 (IgA2 with only the Ca1
constant region) gave similar results. Strikingly, M-like cell-
mediated transport of IgA2 with only the Ca1 constant region
was equivalent to wt m-IgA2. These results demonstrate that in the
in vitro model, the Ca1 region of IgA2 is sufficient to allow reverse
transcytosis through M-like cells.
Influence of Glycosylation on the Uptake of IgA2 by
M-Like Cells
Subclasses of human IgA are also different with respect to the
number of N-glycosylation sites. In order to determine whether N-
glycans present on IgA2 could influence their uptake and transport
by M-like cells, transcytosis of a battery of constructs with
engineered glycosylation sites was compared. As shown in
Figure 4a, the efficiency of reverse transcytosis was highly
dependent on the number of glycosylation sites. Indeed, there
was a significant decrease in the transport of m-IgA2 G2, G1, G0,
and m-IgA2 Ca1 G0 compared with m-IgA2. These findings were
confirmed by enzymatic digestion of m-IgA2 by PNGase, an
amidase that cleaves between the innermost GlcNAc and
asparagine residues of high mannose, hybrid, and complex
oligosaccharides from N-linked glycoproteins.
Sialic acid (Sia) can occur in different glycosidic linkages, most
typically at the exposed, nonreduced ends of oligosaccharide
chains attached to a wide variety of proteins like IgA [24]. To
assess the function of Sia in IgA binding to M-like cells, IgA was
exposed to neuraminidase, which has the capacity to selectively
cleave the glycosidic linkages of neuraminic acids. An important
and significant decrease in transport of IgA2 lacking Sia,
resembling that measured for m-IgA2 G0 or m-IgA2+PNGase,
was observed. Identical results were obtained with another
recombinant IgA2 Ab molecule specific for CD20, with SIgA
purified from colostrum and with plasma IgA treated by
neuraminidase or PNGase (Figure 4b). The absence of remaining
carbohydrates or Sia on the different IgA was verified by Western
blot using labeling with lectins (Figure 4c), while the integrity of the
IgA2 polypeptide following enzymatic treatment was verified by
analysis on SDS-PAA gels (unpublished data). These results
demonstrate the essential role of IgA glycosylation sites, and in
particular, Sia in the reverse transcytosis of IgA2 by M-like cells.
IgA Binds to Intestinal M-Like Cells Via Dectin-1 and
Siglec-5 Receptors
As the above results provide solid evidence of the contribution
of glycosylation to reverse transcytosis, we postulated that the IgA2
receptor of M-like cells is a glucan receptor. Blocking experiments
were performed using a series of b-glucans, mono-, and
disaccharides. A statistically significant decrease in IgA2 transport
was observed in the presence of b-glucans including curdlan,
laminarin, and zymosan (Figure 5a). No inhibition was observed
with other members of the family or with mono- or disaccharides.
To further explore the possible involvement of glycans in IgA2
binding to M-like cells, Abs directed against the most common
sugar receptors were used in blocking experiments. The use of an
anti-Dectin-1 mAb targeting this b-glucan receptor led to an
almost complete inhibition of IgA2 reverse transcytosis (Figure 5b).
In contrast, blocking of the mannose receptor with an anti-CD206
mAb or of the lipopolysaccharide receptor with anti-TLR4 and
anti-CD14 mAbs did not influence IgA2 transport. Consistently,
the presence of Dectin-1 was observed on M-like cells present in
co-culture conditions only (Figure 5c–e). Other receptors that have
been described as being involved in IgA transport were evaluated.
Transferrin receptor expressed by enterocytes (CD71) [25], which
binds IgA1 Abs, did not block IgA2 passage, thus confirming the
exclusive transport of IgA2 by M-like cells. Similarly, targeting of
the human myeloid IgA Fc receptor (CD89) [26] with a specific
mAb did not block the transport of IgA2 (Figure 5b).
To confirm the inability of desialylated IgA2 to target M-like
cells in vitro, blocking experiments were also carried out using
mAbs directed against various Siglecs, a family of receptors that
specifically recognize Sia [27]. The unique involvement of Siglec-5
in IgA2 reverse transcytosis was demonstrated (Figure 5b), in
contrast to all the other members of the family. The surface of M-
like cells was Siglec-5+ in co-culture conditions only, with no
labeling observed in mono-cultures (Figure 5c–e). Moreover, N-
Acetylneuraminic acid severely affected SIgA2 reverse transcytosis
(Figure 5a). Mabs to either Dectin-1 or Siglec-5 strongly inhibited
transport of IgA2 in vitro, reaching up to 90% when added together
(Figure 5b). Binding of monomeric IgA2 and SIgA to Dectin-1 and
Siglec-5 was verified by ELISA using recombinant Dectin-1 and
Siglec-5 as coating molecules (Figure 6a). In support of previous
data, deglycosylated IgA2 and IgA1 were unable to recognize
Dectin-1 and Siglec-5. Specificity of IgA2 recognition was further
confirmed by immunofluorescence (Figure 6b) and flow cytometry
(Figure 6c) using HEK cell transfectants expressing both Dectin-1
and Siglec-5. Importantly, co-localization between partners of the
triad was observed in both types of analyses. Taken together, these
results highlight the prominent role of Dectin-1 and Siglec-5 as
receptors that mediate intestinal IgA2 reverse transcytosis.
In Vivo Specific Uptake and Transport of SIgA Across the
Murine and Human FAE
To verify the validity of data obtained using the in vitro model of
human FAE, SIgA transport was also analyzed in vivo in a mouse
ligated intestinal loop containing a PP [28]. As shown in Figure 7a1
and 7a2, mouse SIgA-Cy3 was present on the surface of, and
inside, UEA-1+ or GP2+ M cells, thus confirming the in vitro
binding data in the in vivo context. Co-localization of mouse SIgA
on Dectin-1+ cells in the FAE confirmed the role of Dectin-1 in
SIgA binding in vivo as well (Figure 7b). In support of these data, in
a Dectin-1 KO mouse model, we observed no co-localization
between SIgA-Cy3 and UEA-1+ M cells and no reverse
transcytosis of SIgA-Cy3 in PPs (Figure 7c). The interaction
between Dectin-1 or Siglec-5 with IgA2 was similarly observed in
human PPs. Immunolabeling with green-labeled IgA2 and red-
labeled Dectin-1 or Siglec-5 of patient biopsies displayed specific
co-localization between the Ab and Dectin-1 (Figure 7d) or Siglec-
5 (Figure 7e). No specific immunofluorescence of secondary IgG
Abs was obtained on human M cells (Figure 7f).
Mouse Oral Immunization with SIgA Serving as a Delivery
Vehicle for HIV-1 p24
These results prompted us to compare the outcome of oral
immunization in wt C57BL/6 mice and Dectin-1 KO mice using
SIgA as an intestinal delivery system targeting M cells. As Dectin-1
is also expressed by DCs or macrophages, one can argue that such
cells intercalating within the FAE may ‘‘pollute’’ the Dectin-1
signal on M cells in vivo. To solve this issue, Dectin-1 KO mice
reconstituted with wt bone marrow cells (chimeric-KO:wt) and wt
mice reconstituted with Dectin-1 KO bone marrow cells
(chimeric-wt:KO) were immunized. Confirmation of the correct
Glycan-Dependent SIgA Reverse Transcytosis
PLOS Biology | www.plosbiology.org 6 September 2013 | Volume 11 | Issue 9 | e1001658
reconstitution in the chimeric mice was obtained by flow
cytometry (Figure 8a/b) and immunofluorescence (Figure 8c)
analysis on peripheral blood leukocytes. Positive control of
immunization was obtained by subcutaneous administration of
nanoparticulated vaccine polylactic acid (PLA)-p24, which in-
duced strong immune response in mice (Figure 8d/e) [29].
HIVp24 was chosen as a vaccine candidate antigen for its
relatively low molecular weight, thus reducing the risk of
Figure 4. Influence of glycosylation and sialylation on the uptake of m-IgA2 by M-like cells. (a) Mono- and co-cultures were incubated for
90 min at 37uC with various hypoglycosylated, or enzymatically deglycosylated, IgA2 constructs, and transported recombinant IgA (m-IgA2) was
evaluated by associated luminescence (n= 4). PNGase, Peptide N:glycosidase; Neura, neuraminidase. (b) Same set of experiments performed with
recombinant anti-CD20 m-IgA2, human colostrum SIgA, and plasma-purified IgA; transported IgA was measured by ELISA. (c) IgA deglycosylation and
desialylation was monitored by Western blot analysis using detection with HRP-conjugated lectins Ulex europaeus-1 and wheat germ agglutinin,
respectively. Lane content: 1, m-IgA2 G0; 2, m-IgA2 G2; 3, m-IgA2; 4, colostrum SIgA+PNGase; 5, colostrum SIgA.
doi:10.1371/journal.pbio.1001658.g004
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disturbing the overall structure of SIgA after covalent coupling.
Administration of p24-SIgA in an intestinal ligated loop resulted in
the presence of the complex in the SED region of PPs (unpublished
data). Moreover, p24-SIgA complexes administered orally co-
localized with Dectin-1+ cells in the FAE region (Figure 9a). Oral
immunizations with p24-SIgA were performed in wt, Dectin-1
KO, chimeric-wt:KO, and chimeric-KO:wt mice as described in
the Methods section. As intestinal immunization is well known to
induce both mucosal and systemic responses [30], serum and feces
samples were collected 1 wk after the last immunization. p24-
specific IgG and IgA titers were measured following immunization
of wt and chimeric-wt:KO mice only (Figure 9b and 9c).
Figure 5. Structural mapping of sugars affecting transport of IgA2. (a) Mono- and co-cultures were pre-incubated apically with 5 mg of
different mono/polysaccharides and sialic acid, prior to addition of various m-IgA2 constructs for 90 min at 37uC. The concentration of transported
IgA was evaluated by associated luminescence (n= 4). (b) Similar experiments performed with 10 mg of blocking Abs directed against potential
receptors (n=4). Detection of Dectin-1 and Siglec-5 on M-like cells in vitro assessed by (c) immunofluorescence (top view), (d) flow cytometry, and (e)
Western blot analysis using specific mAbs. Only cells or lysates recovered from co-cultures stained positive.
doi:10.1371/journal.pbio.1001658.g005
Glycan-Dependent SIgA Reverse Transcytosis
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Moreover, the levels of p24-specific IgG and IgA responses in
these mice were 25-fold higher than those obtained after oral
immunization with the p24 polypeptide only. No antigen-specific
response was measured in Dectin-1 KO and chimeric-KO:wt
mice, thus confirming the essential role of Dectin-1 in SIgA reverse
transcytosis.
Taken together, these results indicate that reverse transcytosis of
the p24-SIgA complex is strictly Dectin-1-dependent and results in
the potentiated passage of the hooked Ag, which is subsequently
processed to trigger the onset of mucosal and systemic Ab
responses.
Transcytosed SIgA Target DC-Specific Receptors in Vivo
and in Vitro
In order to examine SIgA2 transport from the intestinal lumen
to DCs located in the SED region of PPs, we took advantage of the
recent demonstration that SIgA is recognized by DCs via the DC-
SIGN receptor [31]. SIgA uptake by DCs was analyzed in vivo in a
PP-containing ligated intestinal loop from wt mice with DC-
SIGN-specific immunostaining and from CX3CR1-GFP trans-
genic mice. Figure 10a and 10b show specific localizations of p24-
SIgA on DC-SIGN+ and SIgA-Cy3 on CX3CR1-GFP+ DCs
present in the SED region. However, the strictly equivalent of DC-
Figure 6. IgA2 interacts with Dectin-1 and Siglec-5–expressing cells. (a) Recognition by m-IgA2 of recombinant Dectin-1 and Siglec-5 used as
coating molecules (n= 6), as measured by ELISA. (b) Determination by immunofluorescence of the binding of m-IgA2 to Dectin-1 and Siglec-5
receptors expressed by double-transfected HEK cells. Co-localization resulted in the appearance of yellow areas in the cell periphery. In control
experiments, no binding of IgA1 was detected, and nontransfected HEK cells did not stain (n= 2). (c) In flow cytometry analysis, cells were plotted
according to the FSC and SSC profiles and gated to include only HEK cells. A second selection was performed to include only those cells positive for
Dectin-1 and Siglec-5.
doi:10.1371/journal.pbio.1001658.g006
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SIGN has not been described in mice, yet several homologues
have been documented [32]. We assume that DC-SIGN-positive
staining results from cross-reactivity with one of these murine
homologues.
We next assess the relevance of these findings in the human in
vitro system. HeLa transfectants stably expressing DC-SIGN
added to the compartment bathing the basolateral pole of Caco-2
cells were used as surrogates of DCs populating the SED region of
PPs [33]. Control of DC-SIGN expression was demonstrated by
the inhibition of gp120 binding on HeLa-DC-SIGN+ cells by
specific blocking mAbs (unpublished data). The binding of IgA2
that had previously crossed the monolayer containing M-like cells
was observed by immunostaining of HeLa-DC-SIGN (Figure 10c),
but not with wt HeLa cells used as a negative control. In another
control, CHO expressing Langerin placed in the basolateral
compartment did not bind transcytosed IgA2 (unpublished data).
The transport of integral IgA2 through M cells, and also their
preserved capacity to interact with DC-SIGN+ DC–expressing
cells is another indication of the steps involved to ultimately lead to
immune responses as detected above. These findings have also
been confirmed by flow cytometry using human monocyte-derived
DCs known to express DC-SIGN (Figure 10d).
Figure 7. Specific uptake and transport of SIgA across murine and human FAE. (a) Mouse SIgA-Cy3 incubated for 60 min in a ligated
intestinal loop containing a PP was taken up by M cells. Co-localization was observed with both UEA-1-FITC (a1) and GP2-FITC (a2) (n=3). (b)
Colocalization of SIgA-Cy3 with the Dectin-1 receptor stained in green with a specific mAb in the FAE overlying the PP (n= 2). (c) No entry of SIgA-Cy3
occurred in Dectin-1 KO mice (n= 2). (d–f) Images obtained from patient biopsy samples taken from the distal duodenum. V, villi. Biopsies were
immunolabeled with human GFP-IgA2 and Dectin-1-PE (d) or Siglec-5-PE (e) at room temperature for 2 h. Conspicuous co-localization between GFP-
IgA2 and Dectin-1-PE or Siglec-5-PE was observed (n=2). (f) Negative controls were stained with secondary Abs alone (n=2). On all pictures, dotted
lines delineate the FAE separating the intestinal lumen and the lymphoid tissue (side view).
doi:10.1371/journal.pbio.1001658.g007
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The sum of these data shed light on the biochemical
partners involved in reverse transcytosis of SIgA by PPs. SIgA
is first taken up by M cells via the Dectin-1 receptor and/or
Siglec-5, and is subsequently targeted to mucosal CX3CR1+
DCs bearing the DC-SIGN receptor. In the context of
immune complexes, this process explains the functional
production of mucosal and systemic Ab responses to the
associated antigen.
Figure 8. Phenotypic control of reconstituted chimeric mice and control subcutaneous immunization. Representative flow cytometry
plots of peripheral blood leukocytes showing the absence of Dectin-1 expression by cells isolated from chimeric-wt:KO mice (a) and the presence of
Dectin-1 on cells recovered from chimeric-KO:wt mice (b). Grey, control isotype; black, anti-Dectin-1 mAb. Cells were plotted according to FSC and
SSC profiles and gated to include peripheral blood leukocytes. (c) Detection of Dectin-1 on the FAE of chimeric-wt:KO mice, as confirmed by
immunofluorescence. V, villi. Subcutaneous immunization of Dectin-1 KO mice (n= 3), chimeric-KO:wt mice (n= 3), and chimeric-wt:KO mice (n= 3)
using polylactoglycolic acid (PLA) nanoparticles as a delivery system for the HIV-1 p24 capsid protein. Ab production in serum (d) and feces (e)
samples collected before immunization (D0) and 1 wk after the last immunization (D21) was examined by ELISA. Horizontal bars show the mean
value 6 SEM. Increase of IgG and IgA responses was observed in the serum and feces of all mice at D21 (*p,0.05).
doi:10.1371/journal.pbio.1001658.g008
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Discussion
M cells possess a high transcytotic capacity, allowing a wide
range of materials to be transported including particulate Ags,
soluble macromolecules, and pathogens. They are delivered from
the intestinal lumen to inductive sites of the mucosal immune
system. M cells are also the primary route through which SIgA are
delivered to the GALT. Corthe´sy et al. have previously shown that
after selective interaction with M cells, SIgA are targeted to DCs
located in the SED region of PP, resulting in limited mucosal and
systemic immune responses against a non-self-associated protein
Ag [34]. Selective adherence to the apical surface of M cells is a
prerequisite for efficient transepithelial transport, but the identity
of receptors involved in SIgA endocytosis has remained elusive. In
the current study, we investigated the transport of human SIgA2
across a model mimicking human FAE. At the level of IgA2, we
provide evidence that both the Ca1 domain and associated
glycosylation, more particularly Sia residues, are involved in M-
like cell-mediated reverse transcytosis, while at the receptor level,
both Dectin-1 and Siglec-5 have been identified as essential
partner in the process. Finally, we validate our in vitro results upon
analysis of murine and human tissues, ultimately demonstrating
that Dectin-1/Siglec-5-mediated uptake of SIgA-based complexes
results in productive mucosal and systemic antigen-specific Ab
responses.
Initially, we studied reverse transcytosis of IgA2 across human
M-like cells using a cell culture model that reproduces features of
the FAE tissue. We confirmed that human IgA2, with or without J
chain and/or bound SC, but not IgA1, IgG, or IgE, selectively
bound to the apical surface of in vitro differentiated human M-like
Figure 9. Dectin-1 on M cells is essential for SIgA uptake and elicitation of Ab responses against an associated Ag. (a) Incubation of
p24-SIgA (red, indicated by arrowheads) for 90 min in a ligated intestinal loop containing a PP resulted in the targeting of the complex to Dectin-1+ M
cells in the FAE, as indicated by the appearance of numerous yellow spots. V, villi. (b) Oral immunization of wt mice and chimeric-wt:KO (wt mice
reconstituted with bone marrow cells from Dectin-1 KO mice) with HIVp24-SIgA resulted in the production of antigen-specific seric Abs, whereas
Dectin-1 KO mice and chimeric-KO:wt mice (Dectin-1 KO mice reconstituted with bone marrow cells from wt mice) did not respond. (c) An identical
pattern of Ag-specific Ab production was observed in the feces of immunized mice. Samples were collected 1 wk after the last immunization and Ab
production was measured by ELISA. Horizontal bars show the mean value 6 SEM (*p,0.05).
doi:10.1371/journal.pbio.1001658.g009
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cells. Using a battery of deletion mutants, we demonstrated that
domains Ca2 and Ca3 of IgA2 are dispensable to keep reverse
transcytosis through M-like cells highly active. Low or absent
transport of m-IgA2 dCa3 and m-IgA2 dPB comprising the Ca1
region suggests that subtle structural changes may affect optimal
folding of these two particular recombinant proteins. Our in vitro
results obtained with human cells do not totally correlate with the
in vivo results of Mantis et al., who showed that both domains Ca1
and Ca2 were required for IgA binding to mouse PP M cells [4].
Differences in the expression systems for IgA constructs (deletion
versus domain swab) and the glycosylation pattern may explain
this discrepancy. It is conceivable that a critical density of glycans
must be present to ensure uptake, as was recently described for
Dectin-1 efficiently binding b-glucan polymers [35]. In conclusion,
our study unequivocally demonstrates that IgA transport requires
the presence of the properly glycosylated Ca1 domain within the
Ab structure. The model opens the path toward in vitro assays of
transport across reconstituted FAE, examination of the mecha-
nisms of uptake, and investigation into vaccine or intestinal
microbe delivery.
Sia residues on pathogens interact with Siglecs, which are
expressed in the hemopoietic, immune, and nervous systems.
Glycosylation patterns on pathogens are frequently used for
adherence to, and passage across, the mucosal epithelium and in
particular M cells in the FAE [36–38]. Similarly, it is conceivable
that abundant carbohydrates located on the surface of SIgA may
intervene in the process of selective recognition of M cells. The
sum of our data confirms this working hypothesis, and demon-
strates the prominent influence of glycosylation on the uptake of
IgA2 by M cells. Additional experiments dealing with deletion of
particular glycosylation sites and enzymatic desialylation allowed
us to confirm the role of Sia residues in reverse transcytosis
(Figure 4). Several members of the b-glucan superfamily were also
identified as competitors of IgA2 transcytosis (Figure 5). This adds
to the multiple functions of carbohydrates in SIgA including, for
example, neutralization of bacterial toxins [39] and interaction
with commensal bacteria [40].
Having unraveled the structural features responsible for the
selective transport of SIgA in the reconstituted FAE model, we
sought to identity the receptor(s) by which SIgA is taken up and
Figure 10. Transcytosed SIgA is taken up by DCs via the DC-SIGN receptor. (a, b) p24-SIgA or SIgA-Cy3 incubated for 60 min in a mouse
ligated intestinal loop containing a PP were taken up respectively by DC-SIGN+DCs (a) and CX3CR1+DCs (b) in the SED region, as shown by co-
localization in immunofluorescence images. (c) HeLa cells expressing DC-SIGN bound GFP-IgA2 having previously crossed the monolayer containing
M-like cells in vitro. (d) Binding of IgA2 on DC-SIGN was detected by flow cytometry using monocyte-derived DCs. Cells were labeled with a specific
mAb to DC-SIGN only (left panel), and in combination with IgA2-GFP (right panel). All experiments/analyses were carried out in at least duplicates.
doi:10.1371/journal.pbio.1001658.g010
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transported by M cells. The use of blocking Abs against known
IgA receptors including CD89 and CD71 did not prevent SIgA2
reverse transcytosis. These data, combined with the sufficient role
of the Ca1 region of IgA2 in M-cell-mediated reverse transcytosis,
led to the conclusion that no other known IgA receptor (pIgR,
Fca/m receptor, and the asialoglycoprotein receptor) was involved
in the process. Given the established involvement of Sia and b-
glucan moieties, we speculated that the IgA2 receptor of M cells is
a glucan- and/or Sia-receptor. Our work provides evidence of the
presence of Dectin-1 on M-like cells, together with its involvement
in reverse transcytosis of SIgA2. Dectin-1 is a type II transmem-
brane protein of the C-type lectin family, expressed by myeloid
phagocytes (macrophages, DCs and neutrophils), which recognizes
b-glucans in fungal cell walls and transduces signals triggering
phagocytosis and the production of reactive oxygen species
[41,42]. In contrast, as recognition of soluble ligands by Dectin-
1 does not lead to inappropriate activation signaling [35], its
presence on M cells is consistent with simple SIgA capture and
internalization.
Co-operation between Fc galactosylation and Dectin-1–induc-
ing anti-inflammatory activities suggests that Dectin-1 is capable of
working in combination with other partners in the cell plasma
membrane. In view of the involvement of Sia in IgA2 reverse
transcytosis via M cells, we investigated whether a Siglec receptor
could serve this function. The majority of Siglecs, including CD33-
related Siglecs like Siglec-5, appears to be naturally masked owing
to cis-interactions with adjacent Sia. Unmasking of Siglecs can also
occur in some cases by cellular activation or by exposure to
sialidases. The unmasked Siglec would then be capable of de novo
interactions with surrounding ligands in the environment. This
could result in increased interactions with exogenous materials
including glycosylated SIgA. Such a scenario of Siglec serving as a
co-receptor has been reported in the case of HIV-1 entry mediated
by CD4 in macrophages.
Preparation of murine duodenal ligated loops validated the
results generated in the in vitro model of human FAE. This method
has proven valuable in documenting the interaction of mouse IgA
with PP M cells [4]. Tissue immunolabeling both confirmed the
transport of SIgA2 by UEA-1+ and GP2+ M cells, and that of
murine SIgA by Dectin-1 (Figure 7a and b). However, the absence
of cross-reactivity of the anti-human CD170 mAb prevented us
from confirming the role of Siglec-5 in the reverse transcytosis of
SIgA in mice. Consistent with the in vitro data gathered in the
model based on human cells, human biopsy analyses resulted in
specific co-localization between IgA2-GFP and Dectin-1
(Figure 7d) or Siglec-5 (Figure 7e).
Finally, oral immunization of wt, Dectin-1 KO, or chimeric
mice with p24-SIgA complexes unambiguously demonstrated that
reverse transcytosis of SIgA is strictly dependent on Dectin-1
expressed on M cells. The further confirmation of the essential role
of Dectin-1 in the in vivo context provides an explanation to the
uptake of antigen-bearing SIgA by M cells, a feature resulting in
systemic and mucosal immune responses [43]. The lack of a
murine functional ortholog of human Siglec-5 prevented us from
confirming the associated role of Siglec-5 in SIgA reverse
transcytosis in vivo [44–46].
In vivo, the uptake of murine SIgA by murine CX3CR1+ DCs
present in the GALT could also be documented (Figure 10b). In
the SED region, CX3CR1+ DCs play a central role in antigen
sampling [47]. In contrast to CD103+ DCs, CX3CR1+ cells
represent a nonmigratory gut-resident population, which displays
poor T-cell stimulatory capacity [48,49]. In contrast to CD103+
DCs that serve classical DC functions and initiate adaptive
immune responses in local lymph nodes, CX3CR1+ populations
might modulate immune responses directly in the mucosa and
serve as a first line barrier against invading enteropathogens. This
supports the low activation properties of SIgA targeting antigen to
DCs in the SED region [50,51]. A recent study has shown that
small intestine goblet cells function as passages delivering the low
molecular weight soluble dextran (10 kDa) to CD103+ DCs [52],
which promote IgA production, imprint gut homing on lympho-
cytes, and induce the development of regulatory T cells. As
HIVp24 is administered in the form of a complex with SIgA
(400 kDa), we believe that this pathway need additional charac-
terization before it can be considered as operative for large
molecules.
Transcytosis across M cells is known to enable the selective
transport of particulate antigens in the absence of any assessable
damage [53,54]. This holds true for soluble SIgA, as the
transcytosed Ab released by M cells in the human in vitro and
murine in vivo models was still able to specifically target cells
expressing DC-SIGN in the basolateral environment (Figure 10a/
c/d). In mucosal tissues such as the rectum, uterus, and cervix,
DC-SIGN is abundantly expressed by DCs present in the lamina
propria and PPs, further substantiating the importance of the
localization of DC-SIGN+ DCs as a first line of defense against
viruses and pathogens. Delivery in the form of SIgA-based
immune complexes may thus combine the onset of limited
immune responses, which translates into the absence of spurious
inflammatory reactions. Moreover, this receptor, by binding to
ICAM-3, favors the generation of antigen-specific suppressive
CD4+ T cells, which produce IL-10 [55], a cytokine that
intervenes in both intestinal homeostasis and the production of
local IgA.
This work defines Dectin-1 expressed on the surface of M cells
as a receptor involved in SIgA reverse transcytosis both in vitro and
in vivo. Besides bringing new information on the mechanism
involved in SIgA retro-transport, deciphering the identity of such
receptors may lead to the further development of mucosal vaccines
targeting M cells. In future work, it will be critical to test the
expression of Dectin-1 on other mucous membranes such as
nasal/bronchial, endocervical, or buccal mucosa order to evaluate
the broad applicability of this finding to active and passive
immunization. As a perspective to future works, one can argue
that intestinal villous M cells serving as an antigen gateway for the
sampling of gut bacteria and inducing Ag-specific immune
responses in a PP-independent manner [56] may contribute to
SIgA reverse transcytosis as well.
Methods
Reagents
Pullulan from Aureobasidium pullulans, mannan from Saccharomyces
cerevisiae, a-Lactose, L-fructose, glycogen from bovine liver,
sucrose, curdlan from Alcaligenes faecalis, laminarin from Laminaria
digitata, and zymosan from Saccharomyces cerevisiae were all
purchased from Sigma-Aldrich.
Anti-human Dectin-1/CLEC 7A polyclonal Ab (pAb) (goat
IgG), anti-human CD14 mAb (mouse IgG1), anti-human TLR4
pAb (goat IgG), anti-human CD170 mAb (Siglec-5) (mouse IgG1),
and anti-human CD329 mAb (Siglec-9) (mouse IgG2a) were all
purchased from R&D Systems. Anti-human CD206 mAb (mouse
IgG1) (mannose receptor) was purchased from Ozyme. Anti-
human CD22 mAb (Siglec-2) (mouse IgG1), anti-human CD33
mAb (Siglec-3) (mouse IgG1), anti-human CDw328 mAb (Siglec-
7) (mouse IgG1), and anti-human CD169 mAb (Siglec-1) (mouse
IgG1) were purchased from AbD Serotec. Anti-human CD71
mAb (mouse IgG1) was purchased from Cliniscience. Anti-human
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CD89 mAb (mouse IgG1) was purchased from Abcam. All Abs
were blocking and used according to the procedure provided by
the manufacturer.
Yellow-green carboxylated or aminated latex particles (Fluo-
Spheres) with a mean diameter of 0.2 mm were purchased from
Molecular Probes.
Cell Culture
Both the human intestinal cell line Caco-2 cell (clone 1)
(obtained from Dr. Maria Rescigno, University of Milan-Bicocca,
Milan, Italy) [57] and CHO cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (PAA) supplemented with
10% (v/v) fetal bovine serum (FBS, Thermo-Fisher), 1% (v/v)
nonessential amino-acids (PAA), and 1% (v/v) penicillin-strepto-
mycin (PAA). The human Burkitt’s lymphoma cell line Raji B
(American Type Culture Collection) was cultured in RPMI 1640
supplemented with 10% (v/v) FBS, 1% (v/v) nonessential amino-
acids, 1% (v/v) L-glutamine, and 1% (v/v) penicillin-streptomycin.
Inverted in Vitro Model of the Human FAE
The inverted FAE model (Figure 1a) has been previously
reported [20]. Several major changes were made and are listed
below. Inverted Transwell polycarbonate inserts (12 wells, pore
diameter of 3.0 mm, Corning) were coated with Matrigel, a
basement membrane matrix (BD Biosciences) prepared in pure
DMEM to a final protein concentration of 100 mg/ml for 1 h at
room temperature. The coating solution was removed and
inverted inserts washed with 300 ml of DMEM. Caco-2 cells
(36105), resuspended in 300 ml of supplemented DMEM, were
seeded on the lower insert side and cultured overnight. The inserts
were then inverted and placed in a 12-well culture dish and kept
for 9 d. Raji B cells (56105), resuspended in supplemented
DMEM, were then added to the basolateral compartment of the
Caco-2 cells, and co-cultures were maintained for 5 d. Mono-
cultures of Caco-2 cells, cultivated as above but without the Raji B
cells, were used as controls. Finally, the inserts were inverted in six-
well plates, and a piece of silicon tubing (14620 mm, Labomo-
derne) was placed on the basolateral side of each insert. Cell
monolayer integrity, both in mono- and co-cultures, was
controlled by measurement of TEER using an Endohm tissue
resistance chamber (Endohm-12, World Precision Instruments)
connected to a Millicell-ERS Ohmmeter (Millipore). The resis-
tance of medium alone (9 V6cm2) was considered as background
resistance and subtracted from each TEER value. Barrier function
of the tight junctions was also analyzed by zonula occludens-1
(ZO-1) immunolabeling (see next section).
Establishment of the in Vitro Model of Human FAE
Cells morphologically similar to M cells were discriminated
from Caco-2 cells using transmission electron microscopy (TEM)
and scanning electron microscopy (SEM). TEM and SEM were
used to evaluate morphological cell changes after co-culture with
Raji cells. Mono- and co-cultures were washed twice in HBSS and
fixed in 4% (v/v) formaldehyde. Ultra-thin sections of cell-covered
filters were prepared for TEM analysis by standard methods, as
previously described [58]. Observations were made using a
Hitachi H-800 and a Digital camera Hamamatsu AMT XR40.
Samples processed for SEM analyses were dehydrated, dried at
critical point, and gold coated. Pictures of cell monolayers were
obtained with a Thermo Noran Quest 2 L Hitachi S 3000N. Since
no human-specific M cell markers have yet been identified, the
microvilli-free morphology of M-like cells was used to identify and
quantify them by SEM. Mono-cultures were used as controls.
Characterization and quantification of M-like cells in co-
cultures was further verified by immunolabeling. Inserts were
washed in HBSS to eliminate residual medium, incubated in 4%
paraformaldehyde for 30 min, permeabilized with 0.1% Triton X-
100 (Sigma-Aldrich), and blocked with PBS containing 5% FBS
for 15 min at room temperature. Immunolabeling was performed
using a combination of GFP-IgA2, anti-human ZO-1 mAb
(Invitrogen), and mouse anti-human CA19.9 (Dako) [10]. Each
reagent was diluted to 1/100, and incubated for 2 h at room
temperature. 1/200 dilutions of secondary antibodies labeled with
a fluorochrome were incubated for 1 h at room temperature. After
two washes, inserts were air-dried, mounted with Fluoprep
(BioMerieux), and observed by Immunofluorescence microscopy
(Eclipse Ti, Nikon).
Transport of Nanoparticles in the in Vitro Model
Nanoparticle (NP) (yellow-green fluorescent, 0.2 mm carboxyl-
ate-modified FluoSpheres beads) transport by polarized Caco-2
cells was evaluated in HBSS medium. NP concentration was
adjusted to 4.56109 NPs/ml and vortexed for 1 min to dissociate
possible aggregates. NP suspension was added to the apical side of
cell monolayers (400 ml) and the inserts were incubated at 37uC for
90 min. Basolateral solutions were then sampled and the number
of transported particles was measured by flow cytometry (Facs
Calibur, Becton Dickinson). The measurements were based on
both fluorescence and particle size.
Antibody Production
Light and heavy chain encoding genes from a human TNF-
alpha–specific IgA Ab were cloned in a single vector (pGTRIO)
designed for efficient Ab expression in HEK293 and CHO cell
lines. pGTRIO is a derivative of pVITRO2 (Cayla-InvivoGen,
Toulouse, France), a multigenic plasmid that contains two distinct
transcription units. In pGTRIO, the antibiotic resistance gene is
under the control of the EF1 alpha/HTLV promoter combined
with the CMV enhancer that together constitutes a third
transcription unit with the EF1 polyadenylation signal. The kappa
constant region was cloned downstream of the FerL promoter
together with the CMV enhancer, and the heavy chain constant
regions were cloned downstream of the FerH promoter together
with the human aldolase A enhancer. Unique restriction sites were
introduced upstream of each constant region in order to allow the
cloning of the variable region as SgrAI-BsiWI and AgeI-NheI
fragments for VL and VH, respectively. All variable heavy chain
regions were fused at the C-terminal end of secreted luciferase.
CHO cells were transfected with pGTRIO constructs using the
LyoVec system (Cayla-InvivoGen) in accordance with the
manufacturer’s instructions. Stable transfectants were selected in
antibiotic-containing medium and screened for the production of
Abs with a neutralizing activity on the HEK-Blue TNF-alpha/
IL1-beta reporter cells (Cayla-InvivoGen) stimulated with TNF-
alpha. IgA preparations were purified using Kappa affinity
chromatography, IgG preparations were purified using protein
G affinity chromatography, and IgE preparations were purified
using protein L affinity chromatography. Ig-Luc constructs specific
for TNF-alpha maintained their ability to block the cytokine,
indicating proper assembly and folding. The following Abs were
obtained by this method (Figure 2): human m-IgA2 (monomer);
human GFP-IgA2 (monomer); human d-IgA2 (+ J chain - dimer);
murine m-IgA (monomer); human IgE; human IgG1; human m-
IgA1 (monomer); human m-IgA2 G0 (no glycosylation –
monomer); human m-IgA2 G1 (1 glycosylation (Asn263)- mono-
mer); human m-IgA2 G2 (2 glycosylations (Asn263 and Asn469) –
monomer); human m-IgA2 dPB (without basal part – monomer);
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human m-IgA2 dCa3 (without basal part and Ca3 – monomer);
human m-IgA2 dCa2/3 (without basal part, Ca3 and Ca2 –
monomer); human m-IgA2 Ca1 G0 (only Ca1 without glycosyl-
ation); and human m-IgA2 Ca1 (only Ca1 with glycosylation). M-
IgA2 was desialylated and deglycosylated with neuraminidase and
PNGase, respectively (Enzymatic CarboRelease Kit, QA-Bio).
Purity and assembly of the Abs were controlled by SDS-PAGE
(Figure 2b/c). IgA deglycosylation was detected under normal
conditions by using standard Western blot protocol with a
combination of UEA-1-HRP and WGA-HRP lectins (Sigma-
Aldrich).
For visualization of the mouse SIgA retrotranscytosis, a
polymeric IgA Ab from the hybridoma clone IgAC5 specific to
S. flexneri serotype 5a LPS [59] was obtained as previously
described [60]. Purified free human SC was produced in Chinese
hamster ovary cells [61]. SIgA molecules were obtained by
combining in PBS pIgA molecules with a 2-fold excess of human
SC for 2 h at room temperature according to the conditions
described in the study by Rindisbacher et al. [62]. Cy3-SIgA
molecules were obtained by conjugation with indocarbocyanine
(Cy3) using the FluoroLink mAb Cy3 labeling kit (Amersham
Biosciences) according to the procedure provided by the manu-
facturer.
Antibody Transport in the in Vitro Model
Transport experiments were performed in HBSS at 37uC for
90 min with 10 mg of Ab conjugated with luciferase (Luc).
Basolateral solutions were then recovered and the number of
retro-transcytosed Ab-Luc measured by luminometry (Tristar
LB941, Berthold Technologies) using the Gaussia Luc Assay Kit
(Biolux) according to the procedure provided by the manufacturer.
Ab-Luc transport was expressed as a mean value 6 S.E.M. For
inhibition experiments, cell monolayers were first preincubated
apically with 5 mg of inhibitor in HBSS for 90 min at 37uC, and
washed with HBSS, before adding the Ab-Luc suspension. All
transport experiments were carried out in triplicate and were
standardized with m-IgA2 (ratio RLU/mg of Ab).
Dectin-1 and Siglec-5 Specific ELISAs
Maxisorp 96-well plates were either coated with 50 ml of
recombinant human Dectin-1/CLEC7A (5 mg/ml) (R&D Sys-
tems), 50 ml of recombinant human Siglec-5 (5 mg/ml) (R&D
Systems), or 50 ml of an equal mixture of both Dectin-1 and Siglec-
5 proteins and incubated O/N at 4uC. The wells were then
washed three times with PBS and saturated with 200 ml of
blocking solution (PBS+3% BSA) at room temperature for 1 h.
The blocking solution was then discarded and 100 ml of m-IgA2,
colostrum IgA, m-IgA2+PNGase, or m-IgA1 were added at a
concentration of 5 mg/ml. After 1 h of incubation at room
temperature, wells were washed three times with PBS, and bound
IgA was detected using biotinylated goat anti-human IgA
(Southern Biotech) followed by streptavidin-HRP (Amersham).
Results are expressed as the means of OD 6 SEM.
Protein Administration Into Ligated Loops
Six-week-old C57BL/6 mice were purchased from Charles
River Laboratories (Lyon, France). CX3CR1-GFP transgenic
mice were obtained from Maryline Cossin (Joseph Fourier
University, France). Dectin-1 knockout mice [63], chimeric-
KO:wt mice, chimeric-wt:KO mice, C57BL/6 mice, and
CX3CR1-GFP transgenic mice were hosted at the University
Hospital Unit for animal testing (Saint-Etienne, France). For ileal
loop preparation, mice were starved overnight, anesthetized by
intra-peritoneal injection of a mix of ketamine and xylazine (100
and 10 mg/kg animal weight, respectively), and kept warm at
37uC throughout the surgical procedure. We administered 100 ml
of a 1 mg/ml solution of SIgA-Cy3 or p24-SIgA diluted in PBS
into a 1.5-cm ileal loop containing a PP. Upon completion of the
experiment, the mice were sacrificed by cervical dislocation and
the piece of intestine was removed, extensively washed with PBS,
fixed for 2 h in 3% paraformaldehyde, and included in optimal
cutting tissue (OCT) embedding solution. We captured 7-mm
sections (Leica cryostat model CM1950, Leica Microsystems) on
Ultra+ superfrost microscope slides (VWR International) and
stained for M cells. Slides were washed in PBS to eliminate
residual OCT embedding solution, and blocked with PBS
containing 5% FBS for 30 min at room temperature. Abs diluted
to 20 mg/ml were incubated for 2 h at room temperature. The
slides were then washed in PBS, air-dried, and mounted with
Fluoprep (Biome´rieux). Slides were observed by immunofluores-
cence microscopy (Eclipse, Nikon). Immunolabeling was per-
formed using a combination of UEA-1-FITC (Sigma-Aldrich),
anti-human Dectin-1/CLEC 7A pAb, anti-human CD170 mAb
(R&D Systems), anti-human GP2 mAb (MBL), and p24-specific
Ab directly labeled with PE (Santa Cruz Biotechnology). The
protocol followed the guidance of the regional Ethics Committee
for Animal Testing (CREEA) (Permit Number No. 69387487).
Immunolabeling of Human Peyer’s Patches ex Vivo
Informed and consenting patients who had undergone upper
duodenal endoscopy for routine diagnostic purposes (e.g., dyspep-
sia and chronic diarrhea) with normal intestinal mucosa provided
four to six biopsy samples from the distal duodenum. Biopsies were
fixed for 2 h in 3% paraformaldehyde and included in OCT
embedding solution, before being cryosectioned using a Leica
cryostat model CM1950. We captured 7 mm sections on Ultra+
Superfrost microscope slides, and they were stained for M cells as
described for mouse intestine and observed by immunofluores-
cence microscopy. Immunolabeling was performed using a
combination of GFP-IgA2, anti-human Dectin-1/CLEC 7A
pAb, and anti-human CD170 mAb (R&D Systems).
Generation of Dectin-1 Chimeric KO:wt and wt:KO Mice
We housed 5–9-wk-old Dectin-1 KO and wt C57BL/6 males in
individually ventilated cages at least 7 d prior to being irradiated.
During this time and throughout the remainder of the experiment,
animals were also maintained on sterile food and acidified in sterile
water (containing 0.004% HCl). Animals received two doses of full
body irradiation at 5 Gy (26500 rads). Each dose was separated
by a 3 h interval to limit gastrointestinal problems. Irradiated mice
were returned to individually ventilated cages for 24 h. Bone
marrow was isolated from the femurs and tibia of donor Dectin-1
KO and wt C57BL/6 males under sterile conditions in the
absence of red blood cell lysis. Nucleated cells were counted on a
haemocytometer. Irradiated Dectin-1 KO mice each received
26106 total nucleated bone marrow cells from wt C57BL/6 mice
intravenously via the lateral tail vein. The phenotype of these
mice, named chimeric-KO:wt, is thus wt at the systemic level and
Dectin-1 KO at the mucosal level. Irradiated wt C57BL/6 mice
were similarly injected with the same number of Dectin-1 KO
donor cells. The phenotype of these mice, referred to as chimeric-
wt:KO, is Dectin-1 KO at the systemic level and wt at the local
level. Animals were maintained in individually ventilated cages as
described above for a further 6 wk. Five weeks after bone marrow
injections, 50 ml of tail vein blood was taken from each animal to
characterize the cell phenotype, and red blood cells lysed for 2 min
at room temperature in 16 Pharmlyse buffer. Cells were then
washed twice in phosphate-buffered saline and counted. Cells were
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incubated for 15 min in FACS block (HBSS+2 mM NaN3, 0.5%
BSA, and 5% heat inactivated rabbit serum) containing 6 mg/ml
Fc-receptor blocking mAb (clone 24G2), prior to addition of
10 mg/ml biotinylated anti-Dectin-1 mAb (clone 2A11) or the rat
biotinylated isotype control IgG2b for 30 min on ice. After three
washes in FACS wash (HBSS complemented with 2 mM NaN3
and 0.5% BSA), cells were incubated in FACS block containing 1/
200 APC-conjugated streptavidin (Invitrogen) for 20 min on ice.
Cells washed three times were analyzed on a FACSCalibur
(Becton-Dickinson) and data analyzed using FlowJo software.
In Vivo Delivery of HIVp24-SIgA and Measurement of
p24-Specific Abs
Mice. Dectin-1 KO, chimeric-KO:wt, chimeric-wt:KO, and
wt C57BL/6 mice (Charles River Laboratories, France) were
hosted at the University Hospital Unit for animal testing (Saint-
Etienne, France). The protocol followed the guidelines of the
Ethics Committee of CREEA (Permit Number No. 69387487).
HIVp24-SIgA complexes. HIV-1 p24 capsid protein from
clade B strain (Px Therapeutics, France) was covalently associated
to polymeric SIgAC5 using the Sulfo-KMUS heterobifunctional
crosslinker (Thermo Scientific). Covalent complex formation was
verified by Western blot with a polyclonal anti-HIV-1 serum and
revealed with anti-human IgG HRP-conjugated secondary Ab
(Amersham).
Immunization with HIVp24-SIgA complexes. Mouse oral
immunizations were performed by orogastric intubation with
polyethylene tubing under light anesthesia with isofluroan
(Halocarbon Laboratories). The tubing was introduced at a fixed
distance of 1.8 cm from the incisors. Immunizations consisted of
three administrations of 100 ml at 1-wk intervals. Dectin-1 KO
(n=5), chimeric-KO:wt (n=5), and chimeric-wt:KO (n=5) mice
were immunized with 100 mg of HIVp24-SIgA per administration.
Immunization with HIVp24-PLA complexes (positive
control group). Dectin-1 KO (n=5), chimeric-KO:wt (n=5),
chimeric-wt:KO (n=5), and wt (n=5) C57BL/6 mice were
immunized with 10 mg of HIVp24-PLA nanoparticles (suspended
in 100 ml of PBS) by subcutaneous route. Immunizations consisted
of three administrations of 100 ml at 1-wk intervals.
Measurement of HIVp24-specific IgG and IgA
Abs. Serum and feces samples were recovered 1 wk after the
last immunization. Five fresh feces were collected from each
animal. Feces were incubated with Halt Protease Inhibitor
Cocktail (Thermo Scientific), centrifuged at 16,0006 g, and stored
at 220uC until use. Specific Abs against HIVp24 were measured
using a quantitative ELISA. Maxisorp 96-well plates were coated
with either 50 ml of HIVp24 Ag solution (5 mg/ml in sterile PBS)
or 50 ml of a 1/3,200 dilution of an equal mixture of anti-mouse Ig
kappa and lambda light chain–specific mAbs (Serotec), and then
incubated O/N at 4uC. Murine IgG or IgA immunoglobulins (Igs)
(Southern Biotech) were used as standards. Bound or captured Igs
were detected by incubation with HRP-conjugated goat anti-
mouse (IgG), while IgA was detected using biotinylated goat anti-
mouse IgA (Southern Biotech) followed by streptavidin-HRP
(Amersham). Results are given as the means of concentrations 6
SEM.
Statistical Analysis
Statistical analyses were performed using the InStat version 2.01
from the GraphPad Software, and the unpaired two-tail Mann–
Whitney U test was applied. Significance limit was set at p#0.05.
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